| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 45,622 | 76,507 | ||
| Accounts receivable | 0 | 0 | ||
| Inventory (related party transaction) | 174,788 | 174,788 | ||
| Right of use assets | 0 | 0 | ||
| Total assets | 220,410 | 251,295 | ||
| Accounts payable | 0 | 0 | ||
| Lease liability | 0 | 0 | ||
| Unearned sales revenue | 1,860 | 1,860 | ||
| Unearned service revenue | 37,500 | 62,500 | ||
| Total current liabilities | 39,360 | 64,360 | ||
| Due from the related party | 95,588 | 95,588 | ||
| Long-term liabilities | 189,250 | 189,250 | ||
| Less discount on long-term liabilities | -8,965 | -11,065 | ||
| Total liabilities | 315,233 | 338,133 | ||
| Common stock, 0.0001 par value, 300,000,000 shares authorized, 99,000,000 issued and outstanding at december 31, 2024 99,000,000 issued and outstanding at september 30, 2025 | 9,900 | 9,900 | ||
| Additional paid-in capital | 1,302,504 | 1,302,504 | ||
| Retained earnings | -1,407,226 | -1,399,241 | ||
| Total stockholders' equity | -94,823 | -86,838 | ||
| Total liabilities and stockholders' equity | 220,410 | 251,295 | ||
GOLDENWELL BIOTECH, INC. (GWLL)
GOLDENWELL BIOTECH, INC. (GWLL)